LEBANON, NH, New Hampshire medicine technology company PharmaSecure Inc. has landed $2.5 million of a planned $6 million in new funding, according to documents filed with the SEC. According to a report from MHT, previous investors include Gray Ghost, Tech Coast Angels and Life Science Angels.

PharmaSecure was started in 2007 in order to make appropriate anti-counterfeiting technologies available in at-risk, price-sensitive markets for pharmaceutical manufacturers. Co-founders Nathan Sigworth and N. Taylor Thompson have backgrounds in public health research and entrepreneurship. They saw that there were several technologies that could address the counterfeit drugs issue, but because few of these providers had spent time among consumers and customers in emerging markets, many of these technologies were not optimized for the unique challenges of developing markets and their corresponding export destinations.